Navigation Links
Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
Date:2/4/2010

WALTHAM, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will make a corporate presentation at the 2010 BIO CEO & Investor Conference. The 12th Annual BIO CEO & Investor Conference will take place February 8-9 at the Waldorf-Astoria in New York.

Interleukin Genetics Chief Executive Officer, Lewis H. Bender, will provide an overview of the Company and discuss recent milestones at 1:00 p.m. ET in Park South of the Waldorf-Astoria.

About Interleukin Genetics

Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests that empower consumers to prevent certain chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs.  The Company is headquartered in Waltham, MA.  For more information please visit www.ilgenetics.com.

SOURCE Interleukin Genetics, Inc.'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market
2. Interleukin Genetics Reports Second Quarter 2009 Financial Results
3. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
4. Interleukin Genetics to Present at the 2009 BIO Business Forum
5. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
6. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
7. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
8. Interleukin Genetics Reports Third Quarter 2008 Financial Results
9. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
10. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
11. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ... M.D., President and Chief Executive Officer, will present at the ... in New York on Tuesday, Sept. ... live and archived webcast of the presentation will be accessible ... "News & Events" section. About Oncothyreon ...
(Date:9/2/2014)... 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the ... orders consist of three large odour control systems for waste ... "These orders are consistent with the market resurgence in ... , President and CEO. "After a difficult period of restraint ... beginning to see sales growth. Our lower cost structure, technology ...
(Date:9/2/2014)... BETHESDA, Md. , Sept. 2, 2014  Spherix ... fostering and monetization of intellectual property, today announced that ... three patents to the Company in the month of ... of patents.  The issued patents are: ... , U.S.RE45,081 issued August 19, 2014; and ...
(Date:9/2/2014)... Melbourne, Victoria, Australia (PRWEB) September 02, 2014 ... may provide a cure for chronic tinnitus are seeking ... campaign, run on the Indiegogo platform ( http://igg.me/at/tinaway ), ... designed to be a therapeutic ‘mHealth’ app and is ... the brainchild of a team of biomedical and software ...
Breaking Biology Technology:United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 3tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 4tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 5
... -- China Medicine,Corporation (OTC Bulletin Board: ... leading distributor and developer of prescription ... nutritional and,dietary supplements, medical devices, and ... China ("PRC"), through its wholly-owned U.S,subsidiary, ...
... individual risk of basal,cell carcinoma, and are integrated ... Iceland, Oct. 13 Scientists at,deCODE genetics (Nasdaq: ... common,versions of two single-letter variations in the human ... (BCC), the most common cancer among,people of European ...
... In March 2007, Joe Weitz left his position ... Cables to Go/Lastar Inc. to form American Consumer ... States Air Force veterans he partners with at ... online providers of technology-based connectivity solutions; one that ...
Cached Biology Technology:China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show 2China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show 3deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 2deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 3deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 4 Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off 2
(Date:9/2/2014)... American Society of Human Genetics (ASHG) and the ... the National Institutes of Health, have named Elizabeth ... The Wellington School in Columbus, Ohio, the first ... begins today. , The Genetics and Education Fellowship ... their skills, experience, and network to prepare for ...
(Date:9/2/2014)... of University of Maryland physicists has published new ... make possible new nanostructures and nanotechnologies with huge ... computing advances to new sensor development. , Published ... Communications the Maryland scientists, primary discovery is ... that uses a connector, or "intermedium," nanoparticle to ...
(Date:9/2/2014)... In a new study that could ultimately lead to ... The Scripps Research Institute (TSRI) have adapted a chemical ... for molecules that can treat a form of muscular ... vessel and a disease-causing defect as a catalyst to ... Professor Matthew Disney.,"Because the treatment is synthesized only in ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2New synthesis method may shape future of nanostructures, clean energy 2New synthesis method may shape future of nanostructures, clean energy 3Scripps Florida scientists make diseased cells synthesize their own drug 2
... escape from captivity they could succeed in breeding and ... found. Their research, published in Evolutionary Applications , ... they are considered for commercial farming. "The ... interest to the aquaculture industry and now genetically modified ...
... to getting our ,body clocks, back in sync and now ... discovered a molecule essential to the process. Researchers ... of light on the circadian clocks (commonly known as ,body ... (QSM), which was intrinsically involved in relaying light-information to the ...
... Kenneth Walsh, PhD, FAHA, the Aram V. ... the Whitaker Cardiovascular Institute at Boston University School ... American Heart Association (AHA) Distinguished Scientist. The AHA ... The AHA created a Distinguished Scientist designation in ...
Cached Biology News:First study into GM Atlantic salmon mating reveals danger of escape to wild gene pool 2Newly discovered molecule essential to resetting 'body clocks' 2BUSM professor selected as American Heart Association Distinguished Scientist 2
... PhosphoPlus™ SAPK/JNK (Thr183/Tyr185) Antibody Kit ... Antibody, Catalog #9251, 200 ul SAPK/JNK ... ul SAPK/JNK Cell Extracts, Catalog #9253, ... Antibody, Catalog #7074, 100 ul Anti-biotin ...
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
...
Anti-human Carcinoma Associated Antigen, Clone 115D8, Monoclonal Antibody Innate Immunity - Tumor Markers...
Biology Products: